These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 7514740)

  • 1. International Workshop on Standardisation of Genotoxicity Test Procedures. Report of in vivo subgroup.
    Tice RR; Shelby MD
    Mutat Res; 1994 Jun; 312(3):287-92. PubMed ID: 7514740
    [No Abstract]   [Full Text] [Related]  

  • 2. International Workshop on Standardisation of Genotoxicity Test Procedures. Summary of major conclusions.
    Kirkland DJ; Galloway SM; Sofuni T
    Mutat Res; 1994 Jun; 312(3):205-9. PubMed ID: 7514734
    [No Abstract]   [Full Text] [Related]  

  • 3. International Workshop on Standardisation of Genotoxicity Test Procedures. Report of the in vitro sub-group.
    Kirkland DJ
    Mutat Res; 1994 Jun; 312(3):211-5. PubMed ID: 7514735
    [No Abstract]   [Full Text] [Related]  

  • 4. Regulatory requirement for three dose levels in rodent genetic toxicity assays.
    Galloway S
    Mutat Res; 1995 Jul; 329(2):213-9. PubMed ID: 7603503
    [No Abstract]   [Full Text] [Related]  

  • 5. Recommendations for the performance of UDS tests in vitro and in vivo.
    Madle S; Dean SW; Andrae U; Brambilla G; Burlinson B; Doolittle DJ; Furihata C; Hertner T; McQueen CA; Mori H
    Mutat Res; 1994 Jun; 312(3):263-85. PubMed ID: 7514739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of the potential in vivo genotoxicity of fluoranthene.
    Stocker KJ; Howard WR; Statham J; Proudlock RJ
    Mutagenesis; 1996 Sep; 11(5):493-6. PubMed ID: 8921511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guidelines for the conduct of micronucleus assays in mammalian bone marrow erythrocytes.
    MacGregor JT; Heddle JA; Hite M; Margolin BH; Ramel C; Salamone MF; Tice RR; Wild D
    Mutat Res; 1987 Oct; 189(2):103-12. PubMed ID: 3657826
    [No Abstract]   [Full Text] [Related]  

  • 8. Report from the working group on the in vivo mammalian bone marrow chromosomal aberration test.
    Tice RR; Hayashi M; MacGregor JT; Anderson D; Blakey DH; Holden HE; Kirsch-Volders M; Oleson FB; Pacchierotti F; Preston RJ
    Mutat Res; 1994 Jun; 312(3):305-12. PubMed ID: 7514742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro genotoxicity testing strategy for nanomaterials and the adaptation of current OECD guidelines.
    Doak SH; Manshian B; Jenkins GJ; Singh N
    Mutat Res; 2012 Jun; 745(1-2):104-11. PubMed ID: 21971291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. International Workshop on Standardisation of Genotoxicity Test Procedures. Commentary.
    Galloway SM
    Mutat Res; 1994 Jun; 312(3):201-3. PubMed ID: 7514733
    [No Abstract]   [Full Text] [Related]  

  • 11. The Assessment of Mutagenicity. Health Protection Branch Mutagenicity Guidelines. Health Protection Branch Genotoxicity Committee, Department of National Health and Welfare, Canada.
    Environ Mol Mutagen; 1993; 21(1):15-37; discussion 46-57. PubMed ID: 8419151
    [No Abstract]   [Full Text] [Related]  

  • 12. Workshop summary: Top concentration for in vitro mammalian cell genotoxicity assays; and report from working group on toxicity measures and top concentration for in vitro cytogenetics assays (chromosome aberrations and micronucleus).
    Galloway S; Lorge E; Aardema MJ; Eastmond D; Fellows M; Heflich R; Kirkland D; Levy DD; Lynch AM; Marzin D; Morita T; Schuler M; Speit G
    Mutat Res; 2011 Aug; 723(2):77-83. PubMed ID: 21255675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of in vitro cytogenetic techniques in nine European laboratories in relation to chromosomal endpoints induced by three model mutagens.
    Sorsa M; Autio K; Abbondandolo A; Carbonell E; Demopoulos N; Garner C; Kirsch-Volders M; Marcos R; Marafante E; Natarajan AT
    Mutat Res; 1992 Jun; 271(3):261-7. PubMed ID: 1378199
    [No Abstract]   [Full Text] [Related]  

  • 14. Assessment of genotoxicity induced by 7,12-dimethylbenz(a)anthracene or diethylnitrosamine in the Pig-a, micronucleus and Comet assays integrated into 28-day repeat dose studies.
    Shi J; Krsmanovic L; Bruce S; Kelly T; Paranjpe M; Szabo K; Arevalo M; Atta-Safoh S; Debelie F; LaForce MK; Sly J; Springer S
    Environ Mol Mutagen; 2011 Dec; 52(9):711-20. PubMed ID: 21976072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-ranging and dose-setting for in vivo genetic toxicology studies.
    Mackay JM; Elliott BM
    Mutat Res; 1992 Feb; 271(1):97-9. PubMed ID: 1371834
    [No Abstract]   [Full Text] [Related]  

  • 16. The current limitations of in vitro genotoxicity testing and their relevance to the in vivo situation.
    Nesslany F
    Food Chem Toxicol; 2017 Aug; 106(Pt B):609-615. PubMed ID: 27591928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integration of Pig-a, micronucleus, chromosome aberration, and Comet assay endpoints in a 28-day rodent toxicity study with 4-nitroquinoline-1-oxide.
    Stankowski LF; Roberts DJ; Chen H; Lawlor T; McKeon M; Murli H; Thakur A; Xu Y
    Environ Mol Mutagen; 2011 Dec; 52(9):738-47. PubMed ID: 22020836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotoxicity of nanomaterials in vitro: treasure or trash?
    Haase A; Luch A
    Arch Toxicol; 2016 Nov; 90(11):2827-2830. PubMed ID: 27743112
    [No Abstract]   [Full Text] [Related]  

  • 19. Mammalian in vivo cytogenetic assays. Analysis of chromosome aberrations in bone marrow cells.
    Preston RJ; Dean BJ; Galloway S; Holden H; McFee AF; Shelby M
    Mutat Res; 1987 Oct; 189(2):157-65. PubMed ID: 3657831
    [No Abstract]   [Full Text] [Related]  

  • 20. Report on the International Workshop on Standardisation of Genotoxicity Test Procedures. Melbourne, February 1993.
    Mutat Res; 1994 Jun; 312(3):195-318. PubMed ID: 7514732
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.